| Product identity | Confirm that the product is specifically labeled as sterile amoxicillin sodium for injection and that the dosage form, strength, route, and presentation match the clinical requirement. | The carton, vial, package insert, and purchase documents show the same generic name, strength, dosage form, and route of administration. | Unclear active ingredient, inconsistent strength, missing dosage form, or labeling that refers only to “amoxicillin” without identifying the injectable sodium formulation. | Do not purchase until the product identity is consistent across all documents and the intended use is confirmed by a qualified healthcare professional. |
| Regulatory authorization | Check whether the product is authorized for sale in the destination market and whether the proposed use complies with local prescription and medicine-importation rules. | A verifiable marketing authorization, product registration record, or legally valid import approval issued by the relevant national medicines authority. | No registration details, unverifiable authorization numbers, offshore-only sales for a regulated market, or instructions to bypass customs or prescription controls. | Buy only through a legally authorized supply channel that can document regulatory compliance in the destination country. |
| Manufacturer quality system | Verify that the manufacturing site operates under current Good Manufacturing Practice requirements applicable to sterile medicines. | A current GMP certificate or inspection record from a recognized medicines regulator, with the site name, address, scope, and validity period matching the product documentation. | Expired certificate, certificate for a different site or dosage form, altered PDF files, or refusal to provide verifiable regulatory evidence. | Pause the order and independently verify the certificate through the issuing authority or an official regulatory database. |
| Batch traceability | Confirm that every unit can be linked to a specific production batch and that the batch information is consistent across the label, carton, invoice, and quality documents. | Batch or lot number, manufacturing date, expiry date, pack size, and product code are present and identical across the supply records. | Missing lot number, mismatched dates, over-labeling that obscures original information, or cartons containing mixed batch details without documentation. | Reject or quarantine any shipment with incomplete or inconsistent traceability information. |
| Certificate of Analysis | Review the batch-specific Certificate of Analysis rather than relying only on a generic product specification. | The document identifies the product and batch and reports relevant tests such as appearance, identification, assay, impurities, sterility, bacterial endotoxins, particulate matter, and container-closure integrity where applicable. | Generic certificate with no batch number, unexplained test methods, missing specifications, no authorized approval, or results that do not correspond to the product label. | Request clarification from the quality department and independently authenticate the document before release for use. |
| Sterility and microbiological controls | Because the product is intended for injection, verify that it is manufactured and released as a sterile medicinal product. | Batch-release documentation confirms compliance with applicable sterile-product requirements, including sterility and bacterial endotoxin controls where required by the approved specification. | Statements such as “medical grade” used instead of sterile-release evidence, damaged sterile seals, visible contamination, or instructions to use non-sterile preparation. | Do not use or distribute a unit if sterility assurance or container integrity is uncertain. |
| Container-closure system | Inspect the vial, stopper, seal, and outer packaging for protection against contamination, moisture, and unauthorized opening. | Intact vial, undamaged elastomeric stopper, secure crimp or seal, legible label, and packaging that corresponds to the approved presentation. | Cracked vial, loose or missing seal, punctured stopper, leakage, powder outside the vial, illegible label, or evidence of tampering. | Quarantine affected units and report suspected damage or tampering to the supplier and relevant quality authority. |
| Appearance before reconstitution | Compare the powder or cake with the approved product description and inspect for abnormal discoloration, moisture, foreign matter, or caking. | Appearance is consistent with the authorized product information, and the vial contains no visible foreign particles or signs of moisture exposure. | Unexpected color change, wet or collapsed powder, particles, broken cake, or any visible contamination. | Do not administer or reconstitute a vial with abnormal appearance; seek a batch-quality assessment. |
| Expiry and remaining shelf life | Check the expiry date at receipt and ensure sufficient remaining shelf life for transport, quarantine, testing, and clinical use. | Expiry date is clearly printed, has not passed, and meets the purchaser’s documented minimum remaining-shelf-life requirement. | Short-dated stock without prior disclosure, altered date printing, missing expiry date, or different expiry dates on inner and outer packaging. | Agree on a minimum remaining shelf life before purchase and document exceptions in writing. |
| Storage and transport | Follow the storage conditions and reconstituted-product handling instructions in the approved package information. Do not assume that all presentations require refrigeration. | The supplier provides temperature requirements, shipping conditions, excursion procedures, and evidence that the shipment remained within the labeled limits. | Uncontrolled transport, exposure to excessive heat or freezing, missing temperature records where required, or storage advice that conflicts with the package insert. | Use a qualified pharmaceutical logistics service and assess any temperature excursion before product release. |
| Supplier license and authorization | Verify that the seller is legally permitted to distribute prescription medicines and, where applicable, sterile injectable products. | Current wholesale, pharmacy, import, or distribution license with a legal entity name, registered address, scope, issuing authority, and validity period. | Sales through anonymous marketplaces, personal payment accounts, unverifiable addresses, pressure to pay outside official channels, or refusal to provide licensing records. | Purchase only from a licensed distributor whose credentials can be checked through an official government or professional registry. |
| Quality agreement and complaint handling | Determine how the supplier manages complaints, recalls, counterfeit concerns, adverse events, and product returns. | Written procedures, a named quality contact, recall communication process, complaint reference numbers, and documented return or quarantine instructions. | No quality contact, no recall process, refusal to investigate complaints, or return policy that prevents reporting damaged or suspect medicines. | Prefer suppliers with documented pharmaceutical quality procedures and responsive post-sale support. |
| Commercial documentation | Ensure that the quotation, purchase order, invoice, and shipping documents accurately identify the product and the supply terms. | Documents include generic name, strength, dosage form, pack size, batch information when available, quantity, price, Incoterms if relevant, shipping conditions, and payment details for the licensed legal entity. | Cash-only arrangements, vague product descriptions, inconsistent quantities, hidden fees, or documents issued by unrelated entities. | Reconcile all documents before payment and retain them for traceability and audit purposes. |
| Final receipt inspection | Inspect the shipment before acceptance and compare the physical goods with the purchase order and quality documents. | Correct quantity and product, intact cartons and vials, matching batch and expiry information, acceptable transport condition, and complete documentation. | Wrong product, broken or wet cartons, missing units, mismatched labels, temperature excursion, or suspected counterfeit features. | Place questionable stock in quarantine and release it only after review by the responsible pharmacist or quality professional. |
